Skip to content

European Prosthetic Joint Infection Cohort Study- Hip, Knee and Shoulder Prosthetic Joint Infection

European Prosthetic Joint Infection Cohort Study (EPJIC): Evaluation of the Treatment Approach for Hip, Knee and Shoulder Prosthetic Joint Revision Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02424903
Acronym
EPJIC
Enrollment
5000
Registered
2015-04-23
Start date
2015-05-31
Completion date
2018-12-31
Last updated
2015-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prosthesis-related Infections

Keywords

infection, prosthesis, hip, knee, shoulder

Brief summary

The purpose of the study is to compare different approaches for the treatment of prosthetic joint revisions and to optimize the outcomes in patients with prosthetic joint infections (PJI) by improving the treatment concept of PJI.

Detailed description

The aim of the study is to assess the impact of different surgical and antibiotic therapies on patients admitted for a septic or aseptic revision of the hip, knee or shoulder prosthesis. The decision whether the implant will be retained or removed or antimicrobial treatment is based on criteria of each participating center specialists.The success of different treatment algorithms will be measured in terms of infection free interval, functional outcome and quality of life. All consecutive patients who need a revision surgery to the hip, knee or shoulder will be included. Furthermore the study will investigate different diagnostic tests (microbiological and histological) for the diagnosis and the discrimination of septic and aseptic causes in prosthesis failures. Pathogens (microorganisms isolated from puncture of the joint, tissue samples sonication fluid and blood) will be collected to establish a biobank.The samples are obtained preoperatively and intraoperatively as part of routine care practice. The study is not randomized.

Interventions

None listed

Sponsors

Charite University, Berlin, Germany
CollaboratorOTHER
Pro-Implant Foundation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* subject is older than 18 years of Age * written informed consent has been obtained * subject Needs a Revision surgery of the hip, knee or shoulder prosthesis

Exclusion criteria

* subject is currently enrolled in another investigational study * inability to read and understand the participant's Information * subject is younger than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Infection outcome12 months after surgeryThe infection-free status is defined as absence of clinical (e.g. no fistula), laboratory (e.g. normal C-reactive protein) and radiological signs of infection (e.g. no septic loosening).

Secondary

MeasureTime frameDescription
Functional outcome12 months after surgeryby HARRIS HIP SCORE, CONSTANT SHOULDER SCORE, KNEE SOCIETY SCORE, OXFORD HIP SCORE, OXFORD KNEE SCORE, QUICK DASH SCORE
lifequality evaluation12 months after surgeryby EQ5D5l-score

Countries

Germany

Contacts

Primary ContactMaren Engel
maren.engel@charite.de+4930450652417
Backup ContactAlessandra Catalina Bardelli
alessandra-catalina.bardelli@charite.de+4930450552407

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026